Invention Grant
- Patent Title: Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer
- Patent Title (中): 从短杆菌分离的多肽及其用于治疗癌症的用途
-
Application No.: US14126253Application Date: 2012-06-15
-
Publication No.: US09051562B2Publication Date: 2015-06-09
- Inventor: David Machover , Pascal Bonnarme
- Applicant: David Machover , Pascal Bonnarme
- Applicant Address: FR Paris FR Paris Cedex FR Orsay Cedex
- Assignee: Institut National de la Santé et de la Recherche Médicale (INSERM),INRA (Institut National de la Recherche Agronomique),UNIVERSITE PARIS SUD-PARIS XI
- Current Assignee: Institut National de la Santé et de la Recherche Médicale (INSERM),INRA (Institut National de la Recherche Agronomique),UNIVERSITE PARIS SUD-PARIS XI
- Current Assignee Address: FR Paris FR Paris Cedex FR Orsay Cedex
- Agency: Whitham Curtis Christofferson & Cook, PC
- Priority: EP11305748 20110615
- International Application: PCT/EP2012/061497 WO 20120615
- International Announcement: WO2012/172074 WO 20121220
- Main IPC: C07K14/345
- IPC: C07K14/345 ; A61K38/00 ; C12N9/88 ; C12N9/14 ; C07K14/435
Abstract:
The present invention relates to methods and pharmaceutical compositions for treating cancer. More specifically, the invention relates to a polypeptide isolated from Brevibacterium aurantiacum that shows methionine gamma-lyase and homocysteinase activities. The present invention also relates to the use of such a polypeptide for the treatment of cancer.
Public/Granted literature
- US20140140978A1 POLYPEPTIDES ISOLATED FROM BREVIBACTERIUM AURANTIACUM AND THEIR USE FOR THE TREATMENT OF CANCER Public/Granted day:2014-05-22
Information query
